Related Experiment Video
Updated: Aug 5, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Maternal Smoking and Preterm Birth Among Infants With Orofacial Clefts
Peichun Han1, Renata H Benjamin1, Katherine L Ludorf1
1Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
Insights
Maternal heavy smoking during pregnancy, especially in the second trimester, is linked to preterm birth (PTB) in infants with orofacial clefts (OFCs). This highlights the need for smoking cessation programs for expectant mothers to reduce PTB risks.
Area of Science:
- Reproductive Health
- Pediatric Health
- Birth Defect Research
Background:
- Orofacial clefts (OFCs) are common birth defects.
- Maternal smoking is a known risk factor for adverse pregnancy outcomes.
- The specific impact of smoking on preterm birth (PTB) in infants with OFCs requires further investigation.
Purpose of the Study:
- To assess the association between maternal cigarette smoking and PTB in infants diagnosed with OFCs.
- To examine smoking's impact across different OFC types (cleft lip with/without cleft palate, cleft palate only) and pregnancy timepoints.
Main Methods:
- A population-based retrospective cohort study utilizing data from the National Birth Defects Prevention Study and the Birth Defects Study To Evaluate Pregnancy exposures.
- Analysis included 5618 liveborn infants with OFCs.
- Poisson regression was used to calculate adjusted relative risks (aRRs) for PTB (<37 weeks) associated with maternal smoking (any vs. none, and intensity) at various pregnancy stages.
Main Results:
- 14.5% of infants with OFCs experienced preterm birth.
- Heavy maternal smoking (≥15 cigarettes/day) in the second trimester was significantly associated with PTB in infants with cleft palate only (aRR: 1.89) and extremely-to-very PTB (<32 weeks) in infants with any OFC (aRR: 3.37).
- Associations were generally stronger for cleft palate only compared to cleft lip with/without cleft palate.
Conclusions:
- Heavy maternal smoking during the second trimester may elevate the risk of severe preterm birth in infants with OFCs.
- The findings underscore the critical importance of maternal smoking cessation or reduction during pregnancy to mitigate PTB risks in this vulnerable population.
- Further research may refine understanding of smoking intensity and timing effects on specific OFC subtypes and PTB.
Abstract:
ObjectiveTo evaluate the associations between maternal cigarette smoking and preterm birth (PTB) among infants with orofacial clefts (OFCs).DesignPopulation-based retrospective cohort study.SettingUsing data from the National Birth Defects Prevention Study (NBDPS, 1997-2011 deliveries) and the Birth Defects Study To Evaluate Pregnancy exposureS (2014-2021 deliveries), we evaluated the association between maternal smoking and PTB (<37 weeks) among liveborn infants with cleft lip with/without cleft palate (CL±P), cleft palate only (CP), or any OFC.ParticipantsIn total, 5618 liveborn infants with OFCs (3699 CL±P and 1919 CP).Main Outcome Measure(s)Adjusted relative risks (aRRs) and 95% confidence intervals (CIs) were calculated using Poisson regression, adjusted for covariates. For each OFC group, smoking (any vs none) was evaluated during 5 pregnancy timepoints (eg, first trimester). Analyses were repeated for smoking intensity (none, 1-14, ≥15 cigarettes/day) (NBDPS only). Any smoking and smoking intensity were also evaluated for extremely-to-very (<32 weeks) and moderate-to-late preterm (32 to <37 weeks).ResultsAmong infants with OFCs, 14.5% were born preterm. Heavy smoking (≥15 cigarettes/day vs none) in the second trimester was associated with PTB among infants with CP (aRR: 1.89, 95% CI: 1.03-3.45) and extremely-to-very PTB among infants with any OFC (aRR: 3.37, 95% CI: 1.47-7.73). Associations were generally stronger for CP than for CL±P, though imprecise.ConclusionsHeavy smoking during the second trimester may increase the risk of extremely-to-very PTB in infants with OFCs and PTB among infants with CP, further supporting the importance of promoting maternal smoking cessation or reduction.
Related Concept Videos
Development of the Oral Microbiota
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Teratogenicity
